/PRNewswire/ CERENOVUS, Inc., part of Johnson & Johnson MedTech , today announced positive primary outcomes from the real-world EXCELLENT Registry focused.
/PRNewswire/ CERENOVUS, Inc., part of Johnson & Johnson MedTech , today announced positive primary outcomes from the real-world EXCELLENT Registry focused.
CERENOVUS Reveals Positive Outcomes with Thrombectomy in Global Registry Studying Stroke-Inducing Blood Clots streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.